Tuberculosis (TB)

44 clinical trials · Condition

Record	Firm	Date
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront (NCT07167823)	University of Health Sciences Lahore	2022-01-01
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis (NCT06764576)	IRCCS Azienda Ospedaliero-Universitaria di Bologna	2021-12-19
Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China (NCT06702774)	University of Toronto	2021-11-20
Tuberculosis (TB) Aftermath (NCT04333485)	Johns Hopkins University	2021-01-29
QuantiFERON Access Clinical Performance Study Protocol (NCT04243031)	QIAGEN Gaithersburg, Inc	2020-04-01
Six-months Versus Nine-months ATT for Ocular TB (NCT06613919)	L.V. Prasad Eye Institute	2020-01-01
Xpert MTB/RIF Ultra Trial (NCT07135622)	Nestani Tukvadze	2019-05-27
Assessing the Ability of the T-SPOT®.TB Test (NCT03929705)	Oxford Immunotec	2019-05-02
Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections (NCT03808636)	St George's, University of London	2015-06-01
Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant Diseases (NCT07671508)	MIPO Clinic	2013-05-15
Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) (NCT01875952)	Instituto Nacional de Salud Publica, Mexico	2010-05-01
Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region (NCT00600782)	GlaxoSmithKline	2008-02-05
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults (NCT00146744)	GlaxoSmithKline	2005-07-01
Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults. (NCT00291889)	GlaxoSmithKline	2004-07-01

Track Tuberculosis (TB) automatically

Every clearance here is in the API, with alerts when new ones post.